Radio and PodcastRadio and PodcastLive Radio & Podcasts
111 - Achieve Life Sciences Phase 3 Readout Imminent! Interview with CEO John Bencich artwork
Science & Medicine

111 - Achieve Life Sciences Phase 3 Readout Imminent! Interview with CEO John Bencich

Breaking Biotech by Matthew Lepoire

Apr 1, 202200:28:19Science & Medicine

Achieve Life Sciences is developing Cytisinicline for the treatment of smoking cessation. The drug has been available in Eastern Europe for years, but Achieve has taken the lead to bring this drug to market in developed...

About This Episode

111 - Achieve Life Sciences Phase 3 Readout Imminent! Interview with CEO John Bencich is an episode from Breaking Biotech by Matthew Lepoire. Achieve Life Sciences is developing Cytisinicline for the treatment of smoking cessation. The drug...

Podcast

This episode belongs to Breaking Biotech.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Apr 1, 2022, 00:28:19 long, audio available.

Related Episodes

Continue listening to more episodes from Breaking Biotech.